Neisseria lactamica Protects against Experimental Meningococcal Infection

AUTOR(ES)

Oliver, Kerry J.

FONTE

American Society for Microbiology

RESUMO

Immunological and epidemiological evidence suggests that the development of natural immunity to meningococcal disease results from colonization of the nasopharynx by commensal Neisseria spp., particularly with N. lactamica. We report here that immunization with N. lactamica killed whole cells, outer membrane vesicles, or outer membrane protein (OMP) pools and protected mice against lethal challenge by a number of diverse serogroup B and C meningococcal isolates in a model of bacteremic infection. Sera raised to N. lactamica killed whole cells, OMPs, or protein pools were found to cross-react with meningococcal isolates of a diverse range of genotypes and phenotypes. The results confirm the potential of N. lactamica to form the basis of a vaccine against meningococcal disease.

Documentos Relacionados

• Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection
• Neisseria lactamica and Neisseria polysaccharea as possible sources of meningococcal beta-lactam resistance by genetic transformation.
• Recombinant interleukin-6 protects mice against experimental bacterial infection.
• Cinética do cultivo de Neisseria lactamica em biorreator.
• Septicemia due to Neisseria lactamica.